PRP in 2ry Spontaneous Pneumothorax

Zagazig University

Status and phase: Unknown; Phase 1

Conditions: Pneumothorax Spontaneous Secondary

Treatments: Biological: Platelet Rich Plasma

Study type: Interventional

Funder types: Other

Identifiers

NCT03830645

ZU-IRB#4931-4-11-2018

Details and patient eligibility

About

secondary spontaneous pneumothorax patients will be enrolled ,all of them will receive PRP with different doses and schedules

Enrollment: 40 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• COPD patients developed spontanous pneumothorax and was managed with intercostal tube insertion

Exclusion criteria

• refusal of participation

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

40 participants in 1 patient group

Platelet rich plasma group

Experimental group

Treatment:

Biological: Platelet Rich Plasma